The mission of Emerging Microbes & Infections (EMI) is to provide a new integrated forum to allow for the timely dissemination of large amount of information gathered about microbes and infections, especially ones associated with increasing biological and clinical significance and pathogenic frequency.
As an Open Access journal, all articles in EMI are fully downloadable. Browse some of our most read articles selected from April to June 2021.
|Experimental re-infected cats do not transmit SARS-CoV-2||N. N. Gaudreault, J. D. Trujillo, M. Carossino et al|
|DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses||H. Li, S. Wang, G. Hu et al|
|Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients||Q. Yan, P. He, X. Huang et al|
|Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution||A. Baj, F. Novazzi, A. Genoni et al|
EMI will serve microbiologists, clinicians, public health workers, drug and vaccine developers, as well as policy makers by providing them with updated knowledge encompassing microbes and infections emerging in different countries and regions throughout the world. 2018 Impact Factor: 6.212